{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:38Z","timestamp":1789140458433,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01ES021800"],"award-info":[{"award-number":["R01ES021800"]}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Disease Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Glenn and Karen Leppo"},{"name":"Richard Nicely"},{"name":"Allan and Janice Woll Parkinson's Research Funds"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuro.2017.03.008","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T11:17:16Z","timestamp":1491045436000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss"],"prefix":"10.1016","volume":"60","author":[{"given":"Gelareh","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Edler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelbie","family":"Burchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-610X","authenticated-orcid":false,"given":"Jason R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2017.03.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuro.2016.04.008","article-title":"MPTP neurotoxicity is highly concordant between the sexes among BXD recombinant inbred mouse strains","author":"Alam","year":"2016","journal-title":"Neurotoxicology"},{"issue":"37","key":"10.1016\/j.neuro.2017.03.008_bib0010","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0703219104","article-title":"DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase","volume":"104","author":"Andres-Mateos","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.neuro.2017.03.008_bib0015","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.95.13.7659","article-title":"Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"95","author":"Ara","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/exnr.1997.6648","article-title":"Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice","volume":"148","author":"Bezard","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuro.2017.03.008_bib0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2012.06.025","article-title":"Gene\u2013environment interactions in Parkinson's disease: specific evidence in humans and mammalian models","volume":"57","author":"Cannon","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.neuro.2017.03.008_bib0030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ng1665","article-title":"The origins and uses of mouse outbred stocks","volume":"37","author":"Chia","year":"2005","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neuro.2017.03.008_bib0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0169-328X(02)00659-9","article-title":"Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice","volume":"110","author":"Cook","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.neuro.2017.03.008_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/syn.21875","article-title":"Unexpected toxicity of very low dose MPTP in mice: a clue to the etiology of Parkinson's disease?","volume":"70","author":"Dovero","year":"2016","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.neuro.2017.03.008_bib0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","article-title":"The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse","volume":"5","author":"German","year":"1996","journal-title":"Neurodegeneration"},{"issue":"5","key":"10.1016\/j.neuro.2017.03.008_bib0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","article-title":"Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease","volume":"54","author":"Gibb","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuro.2017.03.008_bib0055","doi-asserted-by":"crossref","first-page":"pe5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS ONE"},{"issue":"44","key":"10.1016\/j.neuro.2017.03.008_bib0060","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","article-title":"The progression of pathology in Parkinson's disease","volume":"1184","author":"Halliday","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2017.03.008_bib0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2012.02.085","article-title":"Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on retinal dopaminergic system in mice","volume":"515","author":"Hamilton","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2017.03.008_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(99)01273-1","article-title":"Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus","volume":"828","author":"Hamre","year":"1999","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfu226","article-title":"Hippocampal ER stress and learning deficits following repeated pyrethroid exposure","volume":"143","author":"Hossain","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.neuro.2017.03.008_bib0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/toxsci\/kfr111","article-title":"Mechanism of pyrethroid pesticide-induced apoptosis: role of calpain and the ER stress pathway","volume":"122","author":"Hossain","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.neuro.2017.03.008_bib0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(90)90389-L","article-title":"Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study","volume":"38","author":"Javoy-Agid","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2017.03.008_bib0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuro.2013.03.010","article-title":"Systems analysis of genetic variation in MPTP neurotoxicity in mice","volume":"37","author":"Jones","year":"2013","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.neuro.2017.03.008_bib0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.410360213","article-title":"Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy","volume":"36","author":"Kastner","year":"1994","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.neuro.2017.03.008_bib0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease \u2013 the gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.03.028","article-title":"Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism","volume":"340","author":"Kozina","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.03.008_bib0120","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates \u2013 clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"5456","key":"10.1016\/j.neuro.2017.03.008_bib0125","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.neuro.2017.03.008_bib0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/exnr.1998.7008","article-title":"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease","volume":"156","author":"Miller","year":"1999","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2017.03.008_bib0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(90)91526-M","article-title":"Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"521","author":"O\u2019Callaghan","year":"1990","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuro.2017.03.008_bib0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"issue":"23","key":"10.1016\/j.neuro.2017.03.008_bib0150","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/0024-3205(88)90189-0","article-title":"Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier","volume":"42","author":"Riachi","year":"1988","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.neuro.2017.03.008_bib0155","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1471-4159.1982.tb11490.x","article-title":"Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain","volume":"39","author":"Rivett","year":"1982","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2017.03.008_bib0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.etp.2011.06.010","article-title":"Resistance of the golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-neurotoxicity is not only related with low levels of cerebral monoamine oxidase-B","volume":"65","author":"Rodr\u00edguez","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"issue":"12","key":"10.1016\/j.neuro.2017.03.008_bib0165","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"issue":"9\u201310","key":"10.1016\/j.neuro.2017.03.008_bib0170","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0531-5565(00)00181-9","article-title":"Mouse models of \u03b1-synucleinopathy and Lewy pathology","volume":"35","author":"Sommer","year":"2000","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.neuro.2017.03.008_bib0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187152712800792785","article-title":"A synopsis on the role of tyrosine hydroxylase in Parkinson's disease","volume":"11","author":"Tabrez","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"issue":"34","key":"10.1016\/j.neuro.2017.03.008_bib0185","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuro.2017.03.008_bib0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2014.01.016","article-title":"Prenatal cigarette smoke exposure causes hyperactivity and aggressive behavior: role of altered catcholamines and BDNF","volume":"254","author":"Yochum","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuro.2017.03.008_bib0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/syn.20089","article-title":"Selective alterations of gene expression in mice induced by MPTP","volume":"55","author":"Xu","year":"2005","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.neuro.2017.03.008_bib0200","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nbd.2007.11.008","article-title":"Transcriptional dysregulation in a transgenic model of Parkinson disease","volume":"29","author":"Yacoubian","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neuro.2017.03.008_bib0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ntt.2011.02.012","article-title":"Genetic-based, differential susceptibility to paraquat neurotoxicity in mice","volume":"33","author":"Yin","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"issue":"10","key":"10.1016\/j.neuro.2017.03.008_bib0210","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1139\/o66-158","article-title":"Properties of purified, soluble monoamine oxidase","volume":"44","author":"Youdim","year":"1966","journal-title":"Can. J. Biochem."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X17300591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X17300591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T22:23:42Z","timestamp":1535927022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X17300591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":42,"alternative-id":["S0161813X17300591"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2017.03.008","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2017.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}